337798
Physical, Sexual and Emotional Child abuse and Cancer: Not Just Another Adverse Childhood Experience
Methods: Data from the 2011 BRFSS (N=120,586) were used. The sample included adults, age 18 and over, from nine different states. Dichotomous measures of physical, and emotional abuse, indicated whether or not a respondent experienced that type of abuse as a child. Similarly, dichotomous measures of ACEs captured experiences that included having parents that were separated or living in a home with an adult drug user. A logistic regression model predicting a lifetime diagnosis of cancer was run. Independent variables included all abuse subtypes, ACEs, age, gender, race and state of residence.
Results: After controlling for ACEs, age, gender, race and state of residence, physical (AOR=1.23; 95% CI: 1.09-1.40), sexual (AOR=1.37; 95% CI: 1.23-1.53) and emotional abuse (AOR=1.10; 95% CI: 1.00-1.21) were independently associated with increased odds of cancer. Among ACEs, only living with a mentally ill adult (AOR=1.17; 95% CI: 1.02-1.33) and living with someone who was jailed (AOR=1.25; 95% CI: 1.00-1.57) increased odds of cancer.
Discussion: All childhood abuse subtypes appear to increase cancer risk. As such, research should avoid treating abuse and ACEs as interchangeable experiences. Current cancer prevention efforts may benefit by targeting child abuse survivors.
Learning Areas:
Chronic disease management and preventionPublic health or related research
Social and behavioral sciences
Learning Objectives:
Explain the difference between child abuse subtypes (i.e. physical, sexual and emotional abuse).
Demonstrate that childhood adversities increase risk for cancer.
Differentiate between child abuse and other adversities.
Keyword(s): Child Abuse, Cancer
Qualified on the content I am responsible for because: I am a graduate student with 5 years of experience analyzing large data sets. The topic covered in this abstract is directly related to my dissertation.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.